7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Hemarthrosis D006395 1 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Prosthesis Failure D011475 1 associated lipids
Tooth Mobility D014086 2 associated lipids
Diabetic Neuropathies D003929 5 associated lipids
Dental Pulp Calcification D003784 2 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Chondrocalcinosis D002805 1 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Hip Dislocation D006617 1 associated lipids
Fluorosis, Dental D009050 1 associated lipids
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Coronary Stenosis D023921 6 associated lipids
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Mandibular Injuries D008338 1 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Bacteremia D016470 9 associated lipids
Bacteroidaceae Infections D016866 2 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Pasteurellaceae Infections D016871 2 associated lipids
Cleidocranial Dysplasia D002973 1 associated lipids
Dental Occlusion, Traumatic D003769 1 associated lipids
Gingival Recession D005889 2 associated lipids
Jaw, Edentulous D007575 1 associated lipids
Jaw, Edentulous, Partially D007576 1 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Hashimoto Disease D050031 1 associated lipids
Osteolysis, Essential D010015 1 associated lipids
Arthralgia D018771 8 associated lipids
Osteophyte D054850 2 associated lipids
Hemophilia A D006467 10 associated lipids
Lymphangioleiomyomatosis D018192 1 associated lipids
Encephalitis D004660 15 associated lipids
Macular Degeneration D008268 5 associated lipids
Mitral Valve Insufficiency D008944 4 associated lipids
Mitral Valve Stenosis D008946 3 associated lipids
Actinomycosis D000196 2 associated lipids
Dental Pulp Exposure D003789 1 associated lipids
Diabetic Foot D017719 1 associated lipids
Alphavirus Infections D018354 1 associated lipids
Angina, Stable D060050 2 associated lipids
Malocclusion, Angle Class I D008311 1 associated lipids
Dyslipidemias D050171 7 associated lipids
Stomatitis D013280 14 associated lipids
Weight Loss D015431 56 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Respirovirus Infections D010253 3 associated lipids
Thinness D013851 11 associated lipids
Obesity, Morbid D009767 8 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Irritable Bowel Syndrome D043183 8 associated lipids
Mastocytoma D034801 3 associated lipids
Tooth Migration D014085 2 associated lipids
Synovitis, Pigmented Villonodular D013586 1 associated lipids
Chondroblastoma D002804 1 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Fibroma, Ossifying D018214 1 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Tinnitus D014012 4 associated lipids
Cherubism D002636 1 associated lipids
Spondylarthropathies D025242 1 associated lipids
Spondylarthritis D025241 1 associated lipids
Tooth Resorption D014091 1 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Labyrinthitis D007762 2 associated lipids
Dentin Dysplasia D003805 1 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Arthropathy, Neurogenic D001177 1 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Foot Injuries D018409 1 associated lipids
Angioid Streaks D000793 1 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
POEMS Syndrome D016878 1 associated lipids
Bone Diseases, Developmental D001848 2 associated lipids
Rheumatic Fever D012213 1 associated lipids
Progeria D011371 3 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Periostitis D010522 1 associated lipids
Urologic Neoplasms D014571 2 associated lipids
Dermatomyositis D003882 2 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Carcinoma, Medullary D018276 2 associated lipids
Venous Thrombosis D020246 11 associated lipids
Bone Diseases, Endocrine D001849 1 associated lipids
Microvascular Angina D017566 2 associated lipids
Carcinoma, Lobular D018275 4 associated lipids
Chronic Disease D002908 7 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Carcinosarcoma D002296 7 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Carcinoid Heart Disease D002275 1 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Ueland T et al. Effects of 12 months of GH treatment on cortical and trabecular bone content of IGFs and OPG in adults with acquired GH deficiency: a double-blind, randomized, placebo-controlled study. 2002 J. Clin. Endocrinol. Metab. pmid:12050246
Sasaki N et al. Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis. 2002 Bone pmid:12052453
Brändström H et al. A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function. 2002 Biochem. Biophys. Res. Commun. pmid:12054556
Wittrant Y et al. Osteoprotegerin differentially regulates protease expression in osteoclast cultures. 2002 Biochem. Biophys. Res. Commun. pmid:12054560
Penno H et al. Osteoprotegerin secretion from prostate cancer is stimulated by cytokines, in vitro. 2002 Biochem. Biophys. Res. Commun. pmid:12054622
Fu M et al. Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells. 2002 Biochem. Biophys. Res. Commun. pmid:12056809
Zhang J et al. PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways. 2002 FEBS Lett. pmid:12067713
Nakamura H et al. Localization of osteoprotegerin (OPG) on bone surfaces and cement lines in rat tibia. 2002 J. Histochem. Cytochem. pmid:12070273
Wynne F et al. Investigation of the genetic influence of the OPG, VDR (Fok1), and COLIA1 Sp1 polymorphisms on BMD in the Irish population. 2002 Calcif. Tissue Int. pmid:12073153
Kim YH et al. Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression. 2002 Exp. Mol. Med. pmid:12085990
Khosla S et al. Correlates of osteoprotegerin levels in women and men. 2002 Osteoporos Int pmid:12086350
Price PA et al. Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment. 2002 J. Bone Miner. Res. pmid:12096831
Xing L et al. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. 2002 J. Bone Miner. Res. pmid:12096833
Zou W and Bar-Shavit Z Dual modulation of osteoclast differentiation by lipopolysaccharide. 2002 J. Bone Miner. Res. pmid:12096834
Koyama H et al. Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. 2002 J. Bone Miner. Res. pmid:12096835
Langdahl BL et al. Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. 2002 J. Bone Miner. Res. pmid:12096838
Zhang J et al. Osteoprotegerin abrogates chronic alcohol ingestion-induced bone loss in mice. 2002 J. Bone Miner. Res. pmid:12096839
Saidenberg Kermanac'h N et al. Osteoprotegerin and inflammation. 2002 Apr-Jun Eur. Cytokine Netw. pmid:12101070
Katagiri T and Takahashi N Regulatory mechanisms of osteoblast and osteoclast differentiation. 2002 Oral Dis pmid:12108759
Lee SK and Lorenzo JA Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures. 2002 Bone pmid:12110442
Shioi A et al. Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. 2002 Circ. Res. pmid:12114316
Lipton A et al. Serum osteoprotegerin levels in healthy controls and cancer patients. 2002 Clin. Cancer Res. pmid:12114435
Biskobing DM et al. Novel therapeutic options for osteoporosis. 2002 Curr Opin Rheumatol pmid:12118183
Whyte MP et al. Osteoprotegerin deficiency and juvenile Paget's disease. 2002 N. Engl. J. Med. pmid:12124406
Krane SM Genetic control of bone remodeling--insights from a rare disease. 2002 N. Engl. J. Med. pmid:12124412
Ziolkowska M et al. High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment. 2002 Arthritis Rheum. pmid:12124857
Campagnuolo G et al. Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis. 2002 Arthritis Rheum. pmid:12124878
Sakata M et al. Osteoprotegerin levels increased by interleukin-1beta in human periodontal ligament cells are suppressed through prostaglandin E(2) synthesized de novo. 2002 Cytokine pmid:12126649
Petersson M et al. Oxytocin stimulates proliferation of human osteoblast-like cells. 2002 Peptides pmid:12126740
Grisar J et al. Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. 2002 J. Rheumatol. pmid:12136902
Chen XW et al. Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. 2002 Biochem. Biophys. Res. Commun. pmid:12150965
Hofbauer LC et al. Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells. 2002 Eur. J. Endocrinol. pmid:12153751
Mundy GR Metastasis to bone: causes, consequences and therapeutic opportunities. 2002 Nat. Rev. Cancer pmid:12154351
Lorget F et al. Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. 2002 Biochem. Biophys. Res. Commun. pmid:12163011
Geoffroy V et al. High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. 2002 Mol. Cell. Biol. pmid:12167715
Uemura H et al. Serum osteoprotegerin/osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers. 2002 J. Endocrinol. pmid:12176675
Ragab AA et al. Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. 2002 Am. J. Physiol., Cell Physiol. pmid:12176725
Ulrich-Vinther M et al. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. 2002 J Bone Joint Surg Am pmid:12177271
Ohmori H et al. Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis. 2002 J. Hum. Genet. pmid:12181640
Armstrong AP et al. A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function. 2002 J. Biol. Chem. pmid:12185073
Cundy T et al. A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. 2002 Hum. Mol. Genet. pmid:12189164
Lee SK et al. 1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts. 2002 J. Immunol. pmid:12193704
Fujita T et al. SPARC stimulates the synthesis of OPG/OCIF, MMP-2 and DNA in human periodontal ligament cells. 2002 J. Oral Pathol. Med. pmid:12201246
Juji T et al. A novel therapeutic vaccine approach, targeting RANKL, prevents bone destruction in bone-related disorders. 2002 J. Bone Miner. Metab. pmid:12203031
Jono S et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. 2002 Circulation pmid:12208791
Sedger LM et al. Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice. 2002 Eur. J. Immunol. pmid:12209637
Hofbauer LC et al. Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland. 2002 J. Cell. Biochem. pmid:12210731
Kondo H et al. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. 2002 J. Bone Miner. Res. pmid:12211438
Hofbauer LC and Schoppet M Osteoprotegerin gene polymorphism and the risk of osteoporosis and vascular disease. 2002 J. Clin. Endocrinol. Metab. pmid:12213849
Arko B et al. Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis. 2002 J. Clin. Endocrinol. Metab. pmid:12213850

Table of Content